Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06854588

POCUS Screening for TAA in Hypertensive Patients in the ED

The investigators are going to recruit hypertensive patients in the emergency department of Prince of Wales Hospital. Point-of-care ultrasound of the aorta and measurements of the aortic diameter will be obtained. Other relevant clinical data will also be obtained for analysis. The primary outcome is the number of patients with a maximum aortic diameter of ≥ 4.5 cm and/or ≥ 50% localized enlarged diameter relative to the adjacent normal segment as indicated by POCUS.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Prince of Wales Hospital

Shatin, NT, Hong Kong

About this study

Investigators trained with point-of-care ultrasound (POCUS) will recruit hypertensive patients in the emergency department (ED) of Prince of Wales Hospital. POCUS will be performed using a handheld ultrasound device to visualise the aortic root, ascending aorta, aortic arch and descending aorta. Measurements of the diameter will be obtained from different segments of the thoracic aorta for analysis. The definition of aortic aneurysm is a maximum aortic diameter of ≥ 4.5 cm and/or ≥ 50% localized enlarged diameter relative to the adjacent normal segment as indicated by POCUS. The primary outcome is the prevalence of thoracic aortic aneurysm (TAA) in hypertensive patients in the ED. The secondary outcomes include the number of patients with confirmed TAA as verified by CTA, BMI for all participants, the number of CTA scans conducted for TAA confirmation, the number of surgical interventions performed among TAA patients, the ICU admission rate, ICU length of stay, hospital length of stay and mortality, proportion of adequate visualisation of POCUS studies obtained, agreement of aortic diameter measurement between CTA and POCUS, and signs and symptoms of TAA patients presenting to the ED. In addition, the investigators will assess the 28-day all-cause mortality and any advanced imaging done outside the ED.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients aged ≥ 18 years attending the ED during the study period
  • Known history of hypertension or newly diagnosed hypertension in the ED

Exclusion criteria

  • Known history of aortic aneurysm or dissection
  • Previous thoracic aortic interventions or endovascular stenting
  • Patients in cardiopulmonary resuscitation
  • Traumatic patients
  • Patients refuse to participate the study

Treatment and study plan

Point-of-care ultrasound

Diagnostic Test

POCUS screening will be conducted to measure the maximum diameters at end diastole of the aortic root, ascending aorta, aortic arch, and descending thoracic aorta.

Primary outcomes

  1. number of patients with a dilated aorta

    Time frame: Day 1

    is the number of patients with a maximum aortic diameter of ≥ 4.5 cm and/or ≥ 50% localized enlarged diameter relative to the adjacent normal segment as indicated by POCUS

Secondary outcomes

  1. number of patients with confirmed TAA

    Time frame: through study completion, an average of 1 year

    number of patients with confirmed TAA as verified by CTA

Other outcomes

  1. BMI for all participants

    Time frame: at the time of recruitment

    BMI in kg/m^2

  2. number of CTA scans

    Time frame: through study completion, an average of 1 year

    number of CTA scans conducted for TAA confirmation

  3. number of surgical interventions

    Time frame: from recruitment to 28 days after

    number of surgical interventions performed among TAA patients

  4. ICU and hospital length of stay

    Time frame: through study completion, an average of 1 year

    ICU and hospital length of stay among patients with treatment for TAA

  5. mortality

    Time frame: from recruitment to 28 days after

    28-day mortality in both TAA and non-TAA patients

  6. proportion of adequate visualisation of POCUS studies obtained

    Time frame: up to 1 year

    proportion of adequate visualisation of POCUS studies (%) obtained during the recruitment period

  7. agreement of aortic diameter measurement

    Time frame: from recruitment to 28 days after if CTA is performed

    agreement of aortic diameter measurement between CTA and POCUS in cm

Study contacts

Contact information is provided by the study sponsor or research team.

Colin A. Graham, Professor

CONTACT

[email protected]

+852 35051698

Rebecca Li, MSc

CONTACT

[email protected]

35051698

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Collaborators

  • Hospital Authority, Hong Kong

Registry information

Official study title

Point-of-care Ultrasound Screening of Thoracic Aortic Aneurysm in Hypertensive Patients in the Emergency Department

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Mar 3, 2025
Registry last updated
Mar 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.